Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Breast 2Sarcoma 1

Conditions

Breast Neoplasms 12Neoplasm Metastasis 6Glioblastoma 4Triple Negative Breast Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2Carcinoma, Non-Small-Cell Lung 2Treatment for Metastatic or Locally Advanced Cervical Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Pre-menopausal Breast Cancer 1Non-Small Cell Lunch Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Locally Advanced Solid Tumor 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Temozolomide 29Bevacizumab 14Radiotherapy 12Trastuzumab 10Lomustine 9Capecitabine 8paclitaxel-Angiopep-2 conjugate 6Nivolumab 6pembrolizumab 5dabrafenib 5abemaciclib 5Radiation 5icotinib 4Surgical Procedures, Operative 4Paclitaxel 4Lapatinib 4Irinotecan 4Flucytosine 4Dianhydrogalactitol 4Corticotropin-Releasing Hormone 4Chlorotoxin 4Carboplatin 4vocimagene amiretrorepvec 3verubulin 3tucatinib 3osimertinib 3motexafin gadolinium 3XL647 3Spermine Synthase 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Brain Neoplasms × NVP-BKM120 × Clear all
NCT02000882 2022-02-07

STAR Cape+BKM120 MBC With Brain Met

US Oncology Research

Phase 2 Completed
10 enrolled 11 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01870726 2018-05-30

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

Novartis

Phase 1/2 Terminated
43 enrolled 22 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01132664 2016-08-17

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

Novartis

Phase 1/2 Terminated
72 enrolled 15 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡